Rabeprazole 20 mg for Erosive Esophagitis-Associated Symptoms in a Large, Community-Based Study: Additional Results
Authors:
- 26 June 2009
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (2) , 338-345
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux DiseaseDigestive Diseases and Sciences, 2005
- Long‐term prevention of erosive or ulcerative gastro‐oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5‐year study in the United StatesAlimentary Pharmacology & Therapeutics, 2005
- Treat the Patients' Main Dyspepsia Complaint, not the ROME CriteriaAmerican Journal of Gastroenterology, 2004
- Acid inhibition on the first day of dosing: comparison of four proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2003
- Onset of symptom relief with rabeprazole: a community‐based, open‐label assessment of patients with erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2002
- Rabeprazole, 20 mg Once Daily or 10 mg Twice Daily, Is Equivalent to Omeprazole, 20 mg Once Daily, in the Healing of Erosive Gastrooesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 2000
- Double‐blind, placebo‐controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjectsAlimentary Pharmacology & Therapeutics, 1998
- Pharmacological Management of Gastro-Oesophageal Reflux DiseaseDrugs, 1995
- The Prevalence of Symptoms Suggestive of Esophageal DisordersScandinavian Journal of Gastroenterology, 1991